|
|||||
|
|
Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes |
|
| Authors: | Noriko Ihana‐Sugiyama Takehiro Sugiyama Hirokazu Tanaka Kohjiro Ueki Yasuki Kobayashi Mitsuru Ohsugi |
| Abstract: | |
| Keywords: | dipeptidyl peptidase‐4 inhibitor metformin type 2 diabetes |